{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-22-009080","form_type":"8-K","ticker":"COSM","cik":"0001474167","company_name":"Cosmos Health Inc.","filed_at":"2022-12-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.776724+00:00","generated_at":"2026-06-21T09:30:35.267637+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Cosmos Holdings shareholders approve reverse split authorization, name change, equity plan","bullets":["All six director nominees elected with 98-99% affirmative votes.","2022 equity incentive plan approved with 98% of votes cast in favor.","Shareholders approved name change amendment (98% affirmative) and authorized board to effect reverse stock split (98% affirmative).","Advisory say-on-pay frequency received 93% support for every three years; say-on-pay compensation approved with 98%.","Quorum of ~37% of outstanding shares (9.85M of 26.37M) was present at the December 2, 2022 meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-22-009080","json":"https://secwatch.observer/filing/0001477932-22-009080.json","markdown":"https://secwatch.observer/filing/0001477932-22-009080.md","text":"https://secwatch.observer/filing/0001477932-22-009080.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1474167/000147793222009080/0001477932-22-009080-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1474167/000147793222009080/cosm_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T09:30:35.267637+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"616ed0a30f771118295541298d601ce08b4266cb","claim":"Cosmos Health Inc. shareholders approved Authorize Board to amend Articles of Incorporation to effect a reverse stock split at the 2022-12-02 meeting.","evidence_excerpt":"6. To authorize the Board of Directors to amend the Articles of Incorporation to effect a reverse stock split of the Company’s outstanding common stock at their discretion: For Against Abstain Broker Non-Vote % Votes Affirmative 9,601,860.07 241,339.00 4,567.00 -0- 98%","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1474167/000147793222009080/0001477932-22-009080-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"reverse split"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-12-02"}],"fact_type":"shareholder_vote"},{"claim_id":"6250abf093a07a027eea78d5c2cf62e7d60c9728","claim":"Cosmos Health Inc. shareholders approved Approve amendment to Articles of Incorporation to change the company's name at the 2022-12-02 meeting.","evidence_excerpt":"5. To approve the amendment to the Company’s Articles of Incorporation to the change the Company’s name: For Against Abstain Broker Non-Vote % Votes Affirmative 9,640,286.00 123,533.00 83,947.07 -0- 98%","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1474167/000147793222009080/0001477932-22-009080-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"charter amendment"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-12-02"}],"fact_type":"shareholder_vote"},{"claim_id":"6845556d8e42fef3045162c1a337d1e0c1cfbde6","claim":"Cosmos Health Inc. shareholders approved Advisory vote to approve compensation of named executive officers (Say on Pay Vote) at the 2022-12-02 meeting.","evidence_excerpt":"4. To cast a non-binding, advisory vote to approve the compensation of our named executive officers (“Say on Pay Vote”): For Against Abstain Broker Non-Vote % Votes Affirmative 9,417,734.07 125,845.00 112,004.00 192,183.00 98%","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1474167/000147793222009080/0001477932-22-009080-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-12-02"}],"fact_type":"shareholder_vote"},{"claim_id":"7f3fcab92ca79b1975c4ec3131b5b4269d43750b","claim":"Cosmos Health Inc. shareholders approved To approve the Company's 2022 equity incentive plan at the 2022-12-02 meeting.","evidence_excerpt":"2. To approve the Company’s equity incentive plan: For Against Abstain Broker Non-Vote % Votes Affirmative 9,425,609.07 143,935.00 86,039.00 192,183.00 98%","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1474167/000147793222009080/0001477932-22-009080-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-12-02"}],"fact_type":"shareholder_vote"},{"claim_id":"977b1af54125638e69a1f64e0d200e174be4c1fb","claim":"Cosmos Health Inc. shareholders voted on Advisory vote on the frequency of say-on-pay votes at the 2022-12-02 meeting.","evidence_excerpt":"3. To cast a non-binding, advisory vote on the frequency with which the Company’s shareholders shall have an advisory say on pay vote on the compensation of the Company’s named executive officers: Every Year Every 2 Years Every 3 Years Abstain Broker Non-Vote % Votes Affirmative 629,811.07 32,783.00 8,986,405.00 6,584.00 192,183.00 93%","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1474167/000147793222009080/0001477932-22-009080-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay frequency"},{"label":"Meeting","value":"2022-12-02"}],"fact_type":"shareholder_vote"},{"claim_id":"cf694b677d5a76b8419ea31a1fcf76f93885b4a6","claim":"Cosmos Health Inc. shareholders approved Election of Directors at the 2022-12-02 meeting.","evidence_excerpt":"1. Election of Directors: Nomination For Withheld Broker Non-Votes % Votes Affirmative 01 - Grigorios Siokas 9,465,343.07 190,240.00 192,183.00 98% 02 - Demetrios G. Demetriades 9,451,581.00 204,002.07 192,183.00 98% 03 - John J. Hoidas 9,546,646.07 108,937.00 192,183.00 99% 04 - Dr. Anastasios Aslidis 9,533,573.00 122,010.07 192,183.00 99% 05 - Dr. Manfred Ziegler 9,547,184.07 108,399.00 192,183.00 99%","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1474167/000147793222009080/0001477932-22-009080-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-12-02"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}